A Novel CMKLR1 Small Molecule Antagonist Suppresses CNS Autoimmune Inflammatory Disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel CMKLR1 Small Molecule Antagonist Suppresses CNS Autoimmune Inflammatory Disease
Authors
Keywords
Multiple sclerosis, Enzyme inhibitors, G protein coupled receptors, Central nervous system, Small molecules, White blood cells, Cell migration, Enzyme purification
Journal
PLoS One
Volume 9, Issue 12, Pages e112925
Publisher
Public Library of Science (PLoS)
Online
2014-12-02
DOI
10.1371/journal.pone.0112925
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dimethyl Fumarate (Tecfidera)
- (2014) Jineane V. Venci et al. ANNALS OF PHARMACOTHERAPY
- In Vivo Regulation of Experimental Autoimmune Encephalomyelitis by NK Cells: Alteration of Primary Adaptive Responses
- (2014) R. Winkler-Pickett et al. JOURNAL OF IMMUNOLOGY
- A fingerprint pair analysis of hERG inhibition data
- (2013) Clayton Springer et al. Chemistry Central Journal
- Chemokine-like receptor 1 regulates skeletal muscle cell myogenesis
- (2012) Mark E. Issa et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Expression, Regulation, and Function of Atypical Chemerin Receptor CCRL2 on Endothelial Cells
- (2012) J. Monnier et al. JOURNAL OF IMMUNOLOGY
- Disruption of the Chemokine-Like Receptor-1 (CMKLR1) Gene Is Associated with Reduced Adiposity and Glucose Intolerance
- (2011) Matthew C. Ernst et al. ENDOCRINOLOGY
- The Role of ChemR23 in the Induction and Resolution of Cigarette Smoke-Induced Inflammation
- (2011) T. Demoor et al. JOURNAL OF IMMUNOLOGY
- CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivo axial diffusivity
- (2011) Lillian Cruz-Orengo et al. Journal of Neuroinflammation
- ChemR23 Dampens Lung Inflammation and Enhances Anti-viral Immunity in a Mouse Model of Acute Viral Pneumonia
- (2011) Benjamin Bondue et al. PLoS Pathogens
- Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease
- (2010) M. J. Walters et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characteristics of compounds that cross the blood-brain barrier
- (2009) William A Banks BMC Neurology
- Chemokine-Like Receptor-1 Expression by Central Nervous System-Infiltrating Leukocytes and Involvement in a Model of Autoimmune Demyelinating Disease
- (2009) K. L. Graham et al. JOURNAL OF IMMUNOLOGY
- Mouse ChemR23 Is Expressed in Dendritic Cell Subsets and Macrophages, and Mediates an Anti-Inflammatory Activity of Chemerin in a Lung Disease Model
- (2009) S. Luangsay et al. JOURNAL OF IMMUNOLOGY
- Plasmacytoid Dendritic Cells in Multiple Sclerosis
- (2009) Roberto Lande et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Progressive Multifocal Leukoencephalopathy after Natalizumab Monotherapy
- (2009) Hans Lindå et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synthetic chemerin-derived peptides suppress inflammation through ChemR23
- (2008) Jenna L. Cash et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mast cell–expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis
- (2008) Brian A. Zabel et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chemokine receptor antagonists: overcoming developmental hurdles
- (2008) Richard Horuk NATURE REVIEWS DRUG DISCOVERY
- Melanoma Complicating Treatment with Natalizumab for Multiple Sclerosis
- (2008) John T. Mullen et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started